NCT07085572View on ClinicalTrials.gov

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Adrenal Cortical Carcinoma
Interventions
DRUG

Cemiplimab

350 mg IV Q3W

Trial Locations (1)

25123

RECRUITING

S.C. Oncologia - ASST Spedali Civili di Brescia, Brescia

All Listed Sponsors
lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT07085572 - Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer | Biotech Hunter | Biotech Hunter